Best VCs for Health Technology

82 venture capitalists actively investing in Health Technology.

82
Active VCs
0
Funds
0
Deals
#1Agate Freimane

Founding General Partner

Norrsken VC

Agate backs rapidly scalable businesses where solving a major social or environmental problem improves commercial performance. Her finance, fintech-startup and education experience combines with Norrs

Norrsken VC's live site publishes €1M–€10M early-stage and growth tickets. This is the firm's current range, not Agate's personal check promise; exact initial versus follow-on sizing, ownership and vehicle should be confirmed for each opportunity.
Early StageSeedSeries A
#2Tove Larsson

Founding General Partner

Norrsken VC

Tove backs ambitious European technology companies whose commercial growth directly improves outcomes for people or planet. Her Bain private-equity background and early impact roles add rigorous marke

Norrsken VC currently states €1M–€10M early-stage and growth tickets. This is the firm's range, not Tove's personal promise. Confirm initial ticket, follow-on reserves, ownership and stage with the team.
Early StageSeedSeries A
#3Ilkka Kivimäki

Founding Partner & Advisor of Maki.vc

Maki.vc (Web3)

Ilkka co-built Maki around entrepreneurial DNA, technical depth, non-consensus first-round decisions and Nordic founders with global category ambition. His documented portfolio work spans gaming, smar

Maki Fund III currently states €300K–€3M initial tickets in pre-seed and seed rounds below €5M, with follow-on reserves. This is the active firm's range, not Ilkka's personal or current new-deal authority; his stated remit focuses on existing portfolio companies.
Pre-SeedSeedFirst Institutional Round
#4Nat Turner

Head of Events

Lux Capital

Nat designs the convening layer around Lux's frontier-science and technology network. Her work brings together founders, researchers, executives, investors, journalists and creative leaders in focused

Not applicable to Nat's events role. Lux invests across stages, but no personal allocation authority or check size belongs to this profile. Founder financing pitches should go to Lux's investment team.
Founder and portfolio communityExecutive conveningThought-leadership programming
#5Anna Lundin

Investment Manager

Norrsken VC

Anna combines Norrsken's impact-return mandate with eight years of strategy, operations and international market expansion at Spotify. Her likely value is testing whether an early impact company can t

Norrsken VC currently publishes €1M–€10M early-stage and growth tickets. This is a firm range rather than Anna's personal authority. Confirm geography, initial ticket, ownership, reserves and impact qualification through the firm's pitch process.
Early StageSeedSeries A
#6Douglas Reed

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#7Kim Hodges

Chief Financial Officer

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#8Fred Goldwater

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#9Holden Thorp

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#10Ben Scruggs

Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#11Kseniya Simpson

Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#12Alston Gardner

Special Advisor

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#13Parker Johnson

Head of Investor Relations

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#14Graham Smith

Associate

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#15Declan Devens

Operations Analyst

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#16Lauren P Flickinger

Partner and Fund Manager

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#17Myla Lai-Goldman

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#18Kirkland Hendrickson

Program Manager

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#19Heather Madsen

Operating Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#20John Crumpler

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#21Clay B. Thorp

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#22Kenneth B. Lee, Jr.

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity
#23Carl Soderstrom

Founding Partner

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

$500K-$2M
Startup and growth capital
#24Clay Heighten

Founding Member

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

$500K-$2M
Startup and growth capital
#25JR Garcia

Partner

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

$500K-$2M
Startup and growth capital
#26Lauren Tyra, PhD

Chief Scientific Officer

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

$500K-$2M
Startup and growth capital
#27Daniel S. Parsley

Managing Partner, GPG Ventures - Houston

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

$500K-$2M
Startup and growth capital
#28John Leader

Principal, Investment Operations

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

$500K-$2M
Startup and growth capital
#29Claire England

Investment Partner

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

$500K-$2M
Startup and growth capital
#30Drew Soderstrom

Head of Investor Relations

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

$500K-$2M
Startup and growth capital
#31Ska Sijia Du

Principal

Karma Ventures

The official roster identifies Ska Sijia Du as Principal. This profile applies Karma Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual ma

€1M-€5M published initial ticket range.
Late SeedSeries A
#32Tommi Uhari

Founding Partner

Karma Ventures

The official roster identifies Tommi Uhari as Founding Partner. This profile applies Karma Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individ

€1M-€5M published initial ticket range.
Late SeedSeries A
#33Margus Uudam

Founding Partner

Karma Ventures

The official roster identifies Margus Uudam as Founding Partner. This profile applies Karma Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower indivi

€1M-€5M published initial ticket range.
Late SeedSeries A
#34Kristjan Laanemaa

Founding Partner

Karma Ventures

The official roster identifies Kristjan Laanemaa as Founding Partner. This profile applies Karma Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower i

€1M-€5M published initial ticket range.
Late SeedSeries A
#35Marianne Kikas

Office Manager

Karma Ventures

The official roster identifies Marianne Kikas as Office Manager. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

€1M-€5M published initial ticket range.
Late SeedSeries A
#36Riin Vähk

Finance Manager

Karma Ventures

The official roster identifies Riin Vähk as Finance Manager. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

€1M-€5M published initial ticket range.
Late SeedSeries A
#37Linda Võeras

Venture Partner

Karma Ventures

The official roster identifies Linda Võeras as Venture Partner. This profile applies Karma Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individ

€1M-€5M published initial ticket range.
Late SeedSeries A
#38Auke van den Hout

Managing Partner

Graduate Ventures

The official roster identifies Auke van den Hout as Managing Partner. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrowe

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#39Filip Cuypers

Principal Seed

Graduate Ventures

The official roster identifies Filip Cuypers as Principal Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower indi

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#40Julia Knoeff

Head of Platform

Graduate Ventures

The official roster identifies Julia Knoeff as Head of Platform. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#41Victor de Leeuw

Principal Seed

Graduate Ventures

The official roster identifies Victor de Leeuw as Principal Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower in

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#42Sophie Heijenberg

Investor Seed

Graduate Ventures

The official roster identifies Sophie Heijenberg as Investor Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower i

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#43Rui Li

Associate Principal Seed

Graduate Ventures

The official roster identifies Rui Li as Associate Principal Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower i

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#44Eva Post

Head of Pre-Seed Fund

Graduate Ventures

The official roster identifies Eva Post as Head of Pre-Seed Fund. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#45Daan Keizer

Finance Director

Graduate Ventures

The official roster identifies Daan Keizer as Finance Director. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#46Maiko Kamerbeek

Investor Pre-Seed

Graduate Ventures

The official roster identifies Maiko Kamerbeek as Investor Pre-Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#47Folkert Mullemeister

Compliance Officer

Graduate Ventures

The official roster identifies Folkert Mullemeister as Compliance Officer. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#48Jasper Wennink

Investor Pre-Seed

Graduate Ventures

The official roster identifies Jasper Wennink as Investor Pre-Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#49Kilian Frunz

Analyst Seed

Graduate Ventures

The official roster identifies Kilian Frunz as Analyst Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individ

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#50Karola Szatmári-Philips

Analyst Seed

Graduate Ventures

The official roster identifies Karola Szatmári-Philips as Analyst Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narro

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#51Frederique Serrarens

Platform & Events

Graduate Ventures

The official roster identifies Frederique Serrarens as Platform & Events. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#52Gijs Pot

Analyst Pre-Seed

Graduate Ventures

The official roster identifies Gijs Pot as Analyst Pre-Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individ

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#53Karel Jongen

Analyst Seed

Graduate Ventures

The official roster identifies Karel Jongen as Analyst Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individ

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#54Annick Royaards

Student Investment Team Member

Graduate Ventures

The official roster identifies Annick Royaards as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#55Berend van de Pol

Student Investment Team Member

Graduate Ventures

The official roster identifies Berend van de Pol as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authorit

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#56Evi Vijgeboom

Student Investment Team Member

Graduate Ventures

The official roster identifies Evi Vijgeboom as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#57Hugo Beentjes

Student Investment Team Member

Graduate Ventures

The official roster identifies Hugo Beentjes as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#58Julia d'Hollosy

Student Investment Team Member

Graduate Ventures

The official roster identifies Julia d'Hollosy as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#59Kas Borstlap

Student Investment Team Member

Graduate Ventures

The official roster identifies Kas Borstlap as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#60Lander Hangelbroek

Student Investment Team Member

Graduate Ventures

The official roster identifies Lander Hangelbroek as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authori

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#61Maartje Post van der Burg

Student Investment Team Member

Graduate Ventures

The official roster identifies Maartje Post van der Burg as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#62Marijn de Wit

Student Investment Team Member

Graduate Ventures

The official roster identifies Marijn de Wit as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#63Mila den Hollander

Student Investment Team Member

Graduate Ventures

The official roster identifies Mila den Hollander as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authori

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#64Sem Koelewijn

Student Investment Team Member

Graduate Ventures

The official roster identifies Sem Koelewijn as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#65Sjoerd Boerema

Student Investment Team Member

Graduate Ventures

The official roster identifies Sjoerd Boerema as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority o

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#66Tijn de Kruijff

Student Investment Team Member

Graduate Ventures

The official roster identifies Tijn de Kruijff as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#67Timo Limbourg

Student Investment Team Member

Graduate Ventures

The official roster identifies Timo Limbourg as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or

€75K-€2M published investment range across pre-seed and seed.
Pre-SeedSeed
#68Tom Vanhoutte

Partner & Co-founder

imec.xpand

Tom Vanhoutte is listed by imec.xpand as Partner & Co-founder. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technology r

Not publicly disclosed on the current official site.
#69Peter Vanbekbergen

Partner & Co-founder

imec.xpand

Peter Vanbekbergen is listed by imec.xpand as Partner & Co-founder. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technol

Not publicly disclosed on the current official site.
#70Frank Bulens

Partner

imec.xpand

Frank Bulens is listed by imec.xpand as Partner. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technology risk and accele

Not publicly disclosed on the current official site.
#71Cyril Vančura

Partner

imec.xpand

Cyril Vančura is listed by imec.xpand as Partner. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technology risk and accel

Not publicly disclosed on the current official site.
#72Bert Gyselinckx

Partner

imec.xpand

Bert Gyselinckx is listed by imec.xpand as Partner. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technology risk and acc

Not publicly disclosed on the current official site.
#73Benoit Devogelaere

Partner

imec.xpand

Benoit Devogelaere is listed by imec.xpand as Partner. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technology risk and

Not publicly disclosed on the current official site.
#74Michael Engelmann

Principal

imec.xpand

Michael Engelmann is listed by imec.xpand as Principal. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technology risk and

Not publicly disclosed on the current official site.
#75Jonathan Fajardo Cortes

Principal

imec.xpand

Jonathan Fajardo Cortes is listed by imec.xpand as Principal. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technology ri

Not publicly disclosed on the current official site.
#76Moritz Müller

Investment Associate

imec.xpand

Moritz Müller is listed by imec.xpand as Investment Associate. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technology r

Not publicly disclosed on the current official site.
#77Marrit van den Heuvel

Portfolio Manager

imec.xpand

Marrit van den Heuvel is listed by imec.xpand as Portfolio Manager. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technol

Not publicly disclosed on the current official site.
#78Tine Nelissen

Marketing & Communications

imec.xpand

Tine Nelissen is listed by imec.xpand as Marketing & Communications. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce techno

Not publicly disclosed on the current official site.
#79João Pedro Roque

Principal

Indico Capital

João evaluates Southern European technology companies through a combined engineering, investment-banking, private-equity and venture lens. The documented firm mandate favors globally ambitious founder

Indico's live technology mandate states mostly Pre-Seed through Series A investments of €500K–€10M, with selective Series B/C participation. This is the firm's range rather than João's personal authority; founders should confirm vehicle, initial ticket and reserves.
Pre-SeedSeedSeries A
#80Rui Jerónimo

Principal

Indico Capital

Rui brings long-running Portuguese institutional venture experience to Indico's early-stage Southern European technology mandate. Public evidence supports a broad rather than narrow personal sector re

Indico currently publishes €500K–€10M technology investments, mostly from Pre-Seed through Series A with selective Series B/C. This is the live firm range, not Rui's personal check authority; exact sizing and vehicle should be confirmed directly.
Pre-SeedSeedSeries A
#81Rui Rodrigues

Partner

Indico Capital

Rui combines venture investing with transaction and corporate-finance discipline. Within Indico's mandate, that supports globally ambitious Southern European technology companies from early validation

Indico's current technology range is €500K–€10M, mostly Pre-Seed through Series A and selectively Series B/C. This is firm-level guidance, not Rui's personal commitment range; founders should confirm the applicable fund, initial size and reserves.
Pre-SeedSeedSeries A
#82Christy Shaffer

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Not publicly specified on the official site
Early stage through value inflectionliquidity